SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-093625
Filing Date
2022-04-01
Accepted
2022-04-01 16:08:01
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A d287450ddefa14a.htm DEFA14A 28005
2 GRAPHIC g287450naa0003.jpg GRAPHIC 1257
3 GRAPHIC g287450naa0004.jpg GRAPHIC 913
4 GRAPHIC g287450naa0005.jpg GRAPHIC 873
5 GRAPHIC g287450naa0006.jpg GRAPHIC 1152
6 GRAPHIC g287450naaa02.jpg GRAPHIC 1258
7 GRAPHIC g287450pc0001.jpg GRAPHIC 2030
  Complete submission text file 0001193125-22-093625.txt   40183
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39335 | Film No.: 22798270
SIC: 2834 Pharmaceutical Preparations